Pathologic gambling in Parkinson's disease: a behavioral manifestation of pharmacologic treatment? (Q31441551)

2 July 2017

title

Pathologic gambling in Parkinson's disease: a behavioral manifestation of pharmacologic treatment? (English)

1 reference

2 July 2017

0 references

1 reference

Molina JA

1

1 reference

2 July 2017

Sáinz-Artiga MJ

2

1 reference

2 July 2017

Fraile A

3

1 reference

2 July 2017

Jiménez-Jiménez FJ

4

1 reference

2 July 2017

Villanueva C

5

1 reference

2 July 2017

Ortí-Pareja M

6

1 reference

2 July 2017

Bermejo F

7

1 reference

2 July 2017

language of work or name

English

0 references

publication date

1 September 2000

1 reference

2 July 2017

1 reference

2 July 2017

volume

15

1 reference

2 July 2017

issue

5

1 reference

2 July 2017

page(s)

869-872

1 reference

Altered dopamine function in pathological gambling

2 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C869%3A%3AAID-MDS1016%3E3.0.CO%3B2-I

What features improve the accuracy of clinical diagnosis in Parkinson's disease: A clinicopathologic study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C869%3A%3AAID-MDS1016%3E3.0.CO%3B2-I

Parkinsonism: onset, progression, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C869%3A%3AAID-MDS1016%3E3.0.CO%3B2-I

Pathological gambling in Spanish children and adolescents: an emerging problem

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C869%3A%3AAID-MDS1016%3E3.0.CO%3B2-I

The DSM-III-R impulse control disorders not elsewhere classified: clinical characteristics and relationship to other psychiatric disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C869%3A%3AAID-MDS1016%3E3.0.CO%3B2-I

Pathological gambling. A psychobiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C869%3A%3AAID-MDS1016%3E3.0.CO%3B2-I

Low platelet monoamine oxidase activity in pathological gambling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C869%3A%3AAID-MDS1016%3E3.0.CO%3B2-I

Subtypes of dopamine receptors involved in the mechanism of reinforcement

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C869%3A%3AAID-MDS1016%3E3.0.CO%3B2-I

Studies of the potential role of the dopamine D1 receptor gene in addictive behaviors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C869%3A%3AAID-MDS1016%3E3.0.CO%3B2-I

Association of polymorphisms of dopamine D2 receptor (DRD2), and dopamine transporter (DAT1) genes with schizoid/avoidant behaviors (SAB).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C869%3A%3AAID-MDS1016%3E3.0.CO%3B2-I

Premorbid smoking, alcohol consumption, and coffee drinking habits in Parkinson's disease: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F1531-8257%28200009%2915%3A5%3C869%3A%3AAID-MDS1016%3E3.0.CO%3B2-I

10.1002/1531-8257(200009)15:5<869::AID-MDS1016>3.0.CO;2-I

21 January 2018

Identifiers

DOI

1 reference

2 July 2017

1 reference